This implies that passive immunization with tau antibodies is actually a practical therapeutic goal and the CSF standard of p-tau262/356 or of the microtubule binding domain (MTBD) can function a useful biomarker of tau pathology to observe tau therapeutics in scientific trials.Their Tale laid the foundation for what is shaping up to get a potentia